NANS: A Drug Target / Disease Biomarker (G54187)

Target Name: NANS

NCBI ID: G54187

NANS

NANS: A Drug Target / Disease Biomarker

NANs (Nanomaterials) are a type of advanced materials that have unique properties due to their size, shape, and composition. NANs have been found to be useful in a wide range of applications, including drug delivery, biomedical imaging, and nanotechnology. One particular class of NANs that has gained a lot of attention in recent years is called nanoparticles (NPs), which are small, spherical particles with a diameter of less than 200 nanometers. NPs have a unique ability to interact with biological systems on a nanoscale, which has led to their potential use as drug targets or biomarkers.

Drug delivery is a major application of NPs. NPs have been shown to be able to carry drugs across the blood-brain barrier, which is a difficult process for many drugs to access the central nervous system. This is because NPs are able to aggregate in the blood, which allows them to increase their surface area and improve their ability to bind to drugs. In addition, NPs have been shown to be able to protect drugs from degradation and reduce the amount of drug that is needed, which can improve the efficacy of the drug.

NPs have also been used in biomedical imaging. NPs have been shown to be able to contrast well with biological samples, which makes them useful for imaging structures within the body. NPs have been used to image a variety of biological structures, including blood vessels, tumors, and neural cells. In addition, NPs have been shown to be able to enhance the sensitivity of imaging techniques, which can improve the resolution and accuracy of the images.

NANs have also been used in nanotechnology, which is the study of advanced materials with properties that are unique at the nanoscale. NANs have been shown to be able to perform a wide range of functions, including catalysis, energy storage, and sensors. In addition, NANs have been shown to be able to be used to create new materials with unique properties. For example, NANs have been shown to be able to be used to create materials that are more flexible than traditional materials, which can be useful in a variety of applications.

One of the challenges with NANs is their size and shape, which can make them difficult to manipulate and control. In addition, NANs are often made from a variety of materials, which can affect their properties and behavior. This can make it difficult to predict the interactions between NANs and biological systems. However, researchers are working to overcome these challenges, and NANs are already being used in a wide range of applications.

In conclusion, NANs are a promising class of materials with a wide range of applications. NPs in particular have the potential to be drug targets or biomarkers due to their unique properties, including the ability to interact with biological systems on a nanoscale. While there are still many challenges with NANs, researchers are working to overcome these challenges, and NANs are already being used in a variety of applications. Further research is likely to lead to even more innovative uses for NANs.

Protein Name: N-acetylneuraminate Synthase

Functions: Produces N-acetylneuraminic acid (Neu5Ac) and 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (KDN) (PubMed:10749855, PubMed:27213289). Can also use N-acetylmannosamine 6-phosphate and mannose 6-phosphate as substrates to generate phosphorylated forms of Neu5Ac and KDN, respectively (PubMed:10749855)

The "NANS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NANS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets